New evidence for the beta-adrenergic receptor blocking activity of dihydroergotamine
Chan, P.S.; Ellenbogen, L.
Archives Internationales de Pharmacodynamie et de Therapie 209(2): 204-213
1974
ISSN/ISBN: 0003-9780 PMID: 4155273 Document Number: 70413
Document emailed within 1 workday
Related Documents
Harms, H.H. 1976: Isoproterenol antagonism of cardioselective beta adrenergic receptor blocking agents: a comparative study of human and guinea-pig cardiac and bronchial beta adrenergic receptors Journal of Pharmacology and Experimental Therapeutics 199(2): 329-335Sharma, P.L. 1976: Clinical pharmacology of adrenergic beta-receptor blocking drugs Journal of the Association of Physicians of India 24(11): 729-735
Batlle, F.; Carreño, C.A.; Guetta, N.J.; Vassolo, E.; Bertolasi, C.A. 1970: Treatment of cardiac arrhythmias using a beta adrenergic receptor blocking drug Prensa Medica Argentina 57(38): 1801-1808
Rodrigues, R.; Kornfeld, J.; Pereira, E.M. 1972: Anti-arrhythmic effect of a new adrenergic beta receptor blocking substance Arquivos Brasileiros de Cardiologia 25(6): 471-475
Lydtin, H. 1975: The significance of beta-adrenergic receptor blocking agents in the treatment of hypertension Die Medizinische Welt 6(35): 1487-1492
Madan, B.R.; Gupta, R.S. 1970: Effect of adrenergic beta receptor blocking agents on cardiac output Indian Heart Journal 22(2): 70-72
Nosál', R.; Drábiková, K.; Pecivová, J. 1988: Adverse effects of beta-adrenergic receptor blocking agents on the cellular level Casopis Lekaru Ceskych 127(5): 133-136
Bellomo, G.; Santucci, S.; Murrone, A.; Santambrogio, L.; Gennari, M.; Stangoni, G. 1988: Effects of calcium antagonists and beta-adrenergic receptor blocking agents on cardiovascular rhythmicity Panminerva Medica 30(4): 236-239
Lu, X.R.; Chen, S.M.; Sun, T. 1980: Study of beta-adrenergic receptor blocking effect of extract of root Pueraria pseudo-hirsuta Yao Xue Xue Bao 15(4): 218-222
Singh, K.P. 1979: Modification of hexobarbitone sodium-induced hynosis in mice by beta adrenergic receptor blocking agents Indian Journal of Physiology and Pharmacology 23(1): 52-54
Gombar, V. 1986: Quantitative structure-activity relationships. Fujita-Ban analysis of beta-adrenergic blocking activity of 1-phenoxy-3-([(substituted amido)alkyl]amino)-2-propanols Arzneimittel-Forschung 36(7): 1014-1018
Ziegler, M.G.; Wilner, K.D. 1996: Sertraline does not alter the beta-adrenergic blocking activity of atenolol in healthy male volunteers Journal of Clinical Psychiatry 57(Suppl): 12-15
Thomas, J.A.; Sakai, K.K.; Holck, M.I.; Marks, B.H. 1980: Dopamine-beta-hydroxylase: a modulator of beta adrenergic receptor activity Research Communications in Chemical Pathology and Pharmacology 29(1): 3-13
Balsamo, A.; Lapucci, A.; Macchia, B.; Macchia, M.; Orlandini, E.; Rossello, A.; Ferni, G.; Pinza, M. 1995: Synthesis and adrenergic beta-blocking activity of ortho-, meta- and para-oxypropanolamino-substituted [(benzylideneamino)oxy]propanolamines Farmaco 50(4): 239-243
Newton, G.E.; Parker, J.D. 1996: Acute effects of beta 1-selective and nonselective beta-adrenergic receptor blockade on cardiac sympathetic activity in congestive heart failure Circulation 94(3): 353-358
Waddingham, S.; Riffee, W.R.; Belknap, J.K.; Sheppard, J.R. 1978: Barbiturate dependence in mice: evidence for beta-adrenergic receptor proliferation in brain Research Communications in Chemical Pathology and Pharmacology 20(2): 207-220
Mickey, J.V.; Tate, R.; Mullikin, D.; Lefkowitz, R.J. 1976: Regulation of adenylate cyclase-coupled beta adrenergic receptor binding sites by beta adrenergic catecholamines in vitro Molecular Pharmacology 12(3): 409-419
Andersson, K.E.; Ingemarsson, I. 1975: Inhibition of uterine activity by means of adrenergic beta receptor stimulators Lakartidningen 72(3): 138-141
Sonkodi, S.; Pap, A.; Varró, V. 1976: Effect of the beta-receptor blocking agent visken on blood pressure of hypertensive patients, on plasma renin activity and electrolytes Therapia Hungarica 24(2): 60-62
Holland, M.G. 1974: Autonomic drugs in ophthalmology: Some problems and promises. Section IV: Sympatholytic and sympathetic blocking agents--alpha adrenergic antagonists and beta adrenergic antagonists Annals of Ophthalmology 6(11): 1139-1142